• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MXC
Click for more information
5.00% 6.3¢

MGC PHARMACEUTICALS LTD - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight

MGC Pharmaceuticals Ltd is a medical and cosmetic cannabis company with global operations to supply the legalized markets with cannabis products. The current activities of company include development of non-psychoactive cannabidol (CBD) cosmetic products.
View the full Corporate Spotlight arrow Created with Sketch.

MGC Pharmaceuticals at CannaTech UK

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
MXC Half Yearly Report and AccountsPRICE SENSITIVE28/02/19
MXC Independent Validation of MXC High-Grade Cannabis GeneticsPRICE SENSITIVE26/02/19
MXC MXC Botanical UpdatePRICE SENSITIVE01/02/19
MXC Completion of MGC Derma Sale to CannaGlobalPRICE SENSITIVE29/01/19
MXC Major Regulatory Milestones Achieved for Pharma BusinessPRICE SENSITIVE22/01/19
MXC December Quarterly Activity and Cashflow ReportPRICE SENSITIVE18/01/19
MXC First CannEpil Product arrives in AustraliaPRICE SENSITIVE24/12/18
MXC MGC Derma - CannaGlobal Transaction UpdatePRICE SENSITIVE03/12/18
MXC Chairman's Address - 2018 AGMPRICE SENSITIVE22/11/18
MXC MXC launches CannaHub with RMIT and HUJPRICE SENSITIVE19/11/18
MXC Legal Proceedings Commenced against Varm CosmoPRICE SENSITIVE15/11/18
MXC Reinstatement to Official QuotationPRICE SENSITIVE13/11/18
MXC Definitive Agreement Signed for Sale of MGC DermaPRICE SENSITIVE13/11/18
MXC Suspension from Official QuotationPRICE SENSITIVE05/11/18
MXC Trading HaltPRICE SENSITIVE01/11/18
MXC September Quarterly Activity and Cashflow ReportPRICE SENSITIVE26/10/18
MXC MGC Derma - CannaGlobal Transaction UpdatePRICE SENSITIVE19/10/18
MXC Response to ASX Price and Volume QueryPRICE SENSITIVE16/10/18
MXC Trading HaltPRICE SENSITIVE16/10/18
MXC Pause in TradingPRICE SENSITIVE16/10/18
MXC CannEpil Authorised to Commence Australian SalesPRICE SENSITIVE11/10/18
MXC Trading HaltPRICE SENSITIVE09/10/18
MXC MGC Derma - CannaGlobal Transaction UpdatePRICE SENSITIVE04/10/18
MXC Reinstatement to Official QuotationPRICE SENSITIVE27/09/18
MXC Sale of MGC Derma to Strategic Partner Cannaglobal CanadaPRICE SENSITIVE27/09/18
MXC Suspension from Official QuotationPRICE SENSITIVE25/09/18
MXC Contract Default Notice Issued To Varm CosmoPRICE SENSITIVE25/09/18
MXC Trading HaltPRICE SENSITIVE21/09/18
MXC MXC Signs Major Distribution Agreement for GMP ProductsPRICE SENSITIVE06/09/18
MXC Appendix 4E and Audited 2018 Financial ReportPRICE SENSITIVE03/09/18
MXC MXC to Commence Australian Dementia Trial with Notre DamePRICE SENSITIVE27/08/18
MXC Harvey Nichols Expands MGC Derma Distribution in the UKPRICE SENSITIVE08/08/18
MXC June Quarterly Activity and Cashflow ReportPRICE SENSITIVE30/07/18
MXC MXC Awarded GMP Certification & Manufacturing LicencePRICE SENSITIVE13/07/18 download Created with Sketch. 561.39KB
MXC Trading HaltPRICE SENSITIVE11/07/18 download Created with Sketch. 556.88KB
MXC Harvey Nichols To Sell MGC Derma and Derma Plus CosmeticsPRICE SENSITIVE12/06/18 download Created with Sketch. 557.22KB
MXC Maltese Government Approves Medicinal Cannabis LegislationPRICE SENSITIVE21/05/18
MXC Corporate Update - CEO steps into Managing Director rolePRICE SENSITIVE15/05/18
MXC MGC Derma launches Second Derma Plus CBD ProductPRICE SENSITIVE10/05/18
MXC March Quarterly Activity and Cashflow ReportPRICE SENSITIVE30/04/18
MXC Malta Govt Approval for MC Licensed FacilityPRICE SENSITIVE12/04/18
MXC $5m Placement at 7.0c Closed Stongly OversubscribedPRICE SENSITIVE11/04/18
MXC Contract Secured for Full MC Production Facility in MaltaPRICE SENSITIVE11/04/18
MXC Trading HaltPRICE SENSITIVE09/04/18
MXC Production of First CannEpil Batch Commences at EU FacilityPRICE SENSITIVE29/03/18
MXC MXC Launches MGC Nutraceuticals Product LinePRICE SENSITIVE13/03/18
MXC Updated MXC Operational and Strategy UpdatePRICE SENSITIVE05/03/18
MXC MXC Operational and Strategy UpdatePRICE SENSITIVE05/03/18
MXC Half Yearly Report and AccountsPRICE SENSITIVE26/02/18
MXC MXC Derma Products Officially Launched on Cult Beauty OnlinePRICE SENSITIVE14/02/18
MXC December Quarterly Activity and Cashflow ReportPRICE SENSITIVE31/01/18
MXC Initial GMP Certification for European Production FacilityPRICE SENSITIVE25/01/18
MXC Trading HaltPRICE SENSITIVE23/01/18
MXC MXC Signs Exclusive Distribution Agreement with Cult BeautyPRICE SENSITIVE22/01/18
MXC MXC Welcomes Federal Export LegislationPRICE SENSITIVE05/01/18
MXC MGC Derma Launches CBD Herbal Psoriasis CreamPRICE SENSITIVE04/01/18
MXC Response to ASX queryPRICE SENSITIVE03/01/18
MXC MXC Operational UpdatePRICE SENSITIVE18/12/17
MXC New Year Launch of MGC Derma CBD Psoriasis Cream ConfirmedPRICE SENSITIVE14/12/17
MXC Binding Agreement to Supply $1m CBD Extract AnnuallyPRICE SENSITIVE22/11/17
MXC Definitive Supply Agreement Executed with HL PharmaPRICE SENSITIVE20/11/17
MXC First Varm Cosmo Binding Purchase Order ReceivedPRICE SENSITIVE14/11/17
MXC MXC Enters Multi $M Australian Pharma MarketPRICE SENSITIVE01/11/17
MXC September Quarterly Activity and Cashflow ReportPRICE SENSITIVE01/11/17
MXC First $8m Binding Cosmetics Sales Agreement SignedPRICE SENSITIVE30/10/17
MXC $40 Million White-Label CBD Cosmetics Agreement ExecutedPRICE SENSITIVE20/10/17
MXC MXC Botanic Division Operational UpdatePRICE SENSITIVE13/10/17
MXC Major EU Pharma Supply Agreement Signed with LenisPRICE SENSITIVE03/10/17
MXC Appendix 4E and Audited 2017 Financial ReportPRICE SENSITIVE30/08/17
MXC RMIT and MGC Pharmaceuticals Sign Strategic AgreementPRICE SENSITIVE23/08/17
MXC June Quarterly Activity and Cashflow ReportPRICE SENSITIVE01/08/17
MXC Botanical Division Update - Europe and AustraliaPRICE SENSITIVE03/07/17
MXC First European Distribution Deal Signed for API ProductsPRICE SENSITIVE19/06/17
MXC EU Medical Cannabis License Granted with Strategic AgreementPRICE SENSITIVE05/06/17
MXC Trading HaltPRICE SENSITIVE01/06/17
MXC Positive MGC Derma Clinical Test ResultsPRICE SENSITIVE22/05/17
MXC CEO AppointmentPRICE SENSITIVE10/05/17
MXC Strategic Agreement Signed with RMITPRICE SENSITIVE02/05/17
MXC Trading HaltPRICE SENSITIVE01/05/17
MXC New EU Sales Agreements Signed For MGC DermaPRICE SENSITIVE01/05/17
MXC March Quarterly Activity and Cashflow ReportPRICE SENSITIVE28/04/17
MXC Successful MXC First Cannabinoid ProductionPRICE SENSITIVE10/04/17
MXC European API Extraction Facility CompletedPRICE SENSITIVE05/04/17
MXC Placement of $10m Closed Significantly OversubscribedPRICE SENSITIVE17/03/17
MXC Trading HaltPRICE SENSITIVE15/03/17
MXC Half Yearly Report and AccountsPRICE SENSITIVE28/02/17
MXC Australian Legislation Changes Fast Track MXCPRICE SENSITIVE23/02/17
MXC Cannabinoid Extraction Facility On Target Q2 ProductionPRICE SENSITIVE20/02/17
MXC Medical Cannabis Clinical Study CommencingPRICE SENSITIVE14/02/17
MXC Trading HaltPRICE SENSITIVE09/02/17
MXC Panax Acquisition CompletedPRICE SENSITIVE07/02/17
MXC December Quarterly Activity and Cashflow ReportPRICE SENSITIVE01/02/17
MXC Commencement of Dermatological Clinical TrialsPRICE SENSITIVE25/01/17
MXC European CPNP Approval Granted for Derma ProductsPRICE SENSITIVE09/01/17
MXC MXC Operations UpdatePRICE SENSITIVE22/12/16
MXC New Panax Acquisition Agreement Signed, Settlement ImminentPRICE SENSITIVE15/12/16
MXC First Major European Sales and Revenue for MGC Derma RangePRICE SENSITIVE02/12/16
MXC Cleansing ProspectusPRICE SENSITIVE09/11/16
MXC EU Registration Commenced for CBD Derma Product SalesPRICE SENSITIVE07/11/16
MXC September Quarter Activity and Cashflow Report-MXC.AX PRICE SENSITIVE27/10/16
MXC Half Yearly Report and Accounts
28/02/19PRICE SENSITIVE
MXC Independent Validation of MXC High-Grade Cannabis Genetics
26/02/19PRICE SENSITIVE
MXC MXC Botanical Update
01/02/19PRICE SENSITIVE
MXC Completion of MGC Derma Sale to CannaGlobal
29/01/19PRICE SENSITIVE
MXC Major Regulatory Milestones Achieved for Pharma Business
22/01/19PRICE SENSITIVE
MXC December Quarterly Activity and Cashflow Report
18/01/19PRICE SENSITIVE
MXC First CannEpil Product arrives in Australia
24/12/18PRICE SENSITIVE
MXC MGC Derma - CannaGlobal Transaction Update
03/12/18PRICE SENSITIVE
MXC Chairman's Address - 2018 AGM
22/11/18PRICE SENSITIVE
MXC MXC launches CannaHub with RMIT and HUJ
19/11/18PRICE SENSITIVE
MXC Legal Proceedings Commenced against Varm Cosmo
15/11/18PRICE SENSITIVE
MXC Reinstatement to Official Quotation
13/11/18PRICE SENSITIVE
MXC Definitive Agreement Signed for Sale of MGC Derma
13/11/18PRICE SENSITIVE
MXC Suspension from Official Quotation
05/11/18PRICE SENSITIVE
MXC Trading Halt
01/11/18PRICE SENSITIVE
MXC September Quarterly Activity and Cashflow Report
26/10/18PRICE SENSITIVE
MXC MGC Derma - CannaGlobal Transaction Update
19/10/18PRICE SENSITIVE
MXC Response to ASX Price and Volume Query
16/10/18PRICE SENSITIVE
MXC Trading Halt
16/10/18PRICE SENSITIVE
MXC Pause in Trading
16/10/18PRICE SENSITIVE
MXC CannEpil Authorised to Commence Australian Sales
11/10/18PRICE SENSITIVE
MXC Trading Halt
09/10/18PRICE SENSITIVE
MXC MGC Derma - CannaGlobal Transaction Update
04/10/18PRICE SENSITIVE
MXC Reinstatement to Official Quotation
27/09/18PRICE SENSITIVE
MXC Sale of MGC Derma to Strategic Partner Cannaglobal Canada
27/09/18PRICE SENSITIVE
MXC Suspension from Official Quotation
25/09/18PRICE SENSITIVE
MXC Contract Default Notice Issued To Varm Cosmo
25/09/18PRICE SENSITIVE
MXC Trading Halt
21/09/18PRICE SENSITIVE
MXC MXC Signs Major Distribution Agreement for GMP Products
06/09/18PRICE SENSITIVE
MXC Appendix 4E and Audited 2018 Financial Report
03/09/18PRICE SENSITIVE
MXC MXC to Commence Australian Dementia Trial with Notre Dame
27/08/18PRICE SENSITIVE
MXC Harvey Nichols Expands MGC Derma Distribution in the UK
08/08/18PRICE SENSITIVE
MXC June Quarterly Activity and Cashflow Report
30/07/18PRICE SENSITIVE
MXC MXC Awarded GMP Certification & Manufacturing Licence
13/07/18PRICE SENSITIVE download Created with Sketch. 561.39KB
MXC Trading Halt
11/07/18PRICE SENSITIVE download Created with Sketch. 556.88KB
MXC Harvey Nichols To Sell MGC Derma and Derma Plus Cosmetics
12/06/18PRICE SENSITIVE download Created with Sketch. 557.22KB
MXC Maltese Government Approves Medicinal Cannabis Legislation
21/05/18PRICE SENSITIVE
MXC Corporate Update - CEO steps into Managing Director role
15/05/18PRICE SENSITIVE
MXC MGC Derma launches Second Derma Plus CBD Product
10/05/18PRICE SENSITIVE
MXC March Quarterly Activity and Cashflow Report
30/04/18PRICE SENSITIVE
MXC Malta Govt Approval for MC Licensed Facility
12/04/18PRICE SENSITIVE
MXC $5m Placement at 7.0c Closed Stongly Oversubscribed
11/04/18PRICE SENSITIVE
MXC Contract Secured for Full MC Production Facility in Malta
11/04/18PRICE SENSITIVE
MXC Trading Halt
09/04/18PRICE SENSITIVE
MXC Production of First CannEpil Batch Commences at EU Facility
29/03/18PRICE SENSITIVE
MXC MXC Launches MGC Nutraceuticals Product Line
13/03/18PRICE SENSITIVE
MXC Updated MXC Operational and Strategy Update
05/03/18PRICE SENSITIVE
MXC MXC Operational and Strategy Update
05/03/18PRICE SENSITIVE
MXC Half Yearly Report and Accounts
26/02/18PRICE SENSITIVE
MXC MXC Derma Products Officially Launched on Cult Beauty Online
14/02/18PRICE SENSITIVE
MXC December Quarterly Activity and Cashflow Report
31/01/18PRICE SENSITIVE
MXC Initial GMP Certification for European Production Facility
25/01/18PRICE SENSITIVE
MXC Trading Halt
23/01/18PRICE SENSITIVE
MXC MXC Signs Exclusive Distribution Agreement with Cult Beauty
22/01/18PRICE SENSITIVE
MXC MXC Welcomes Federal Export Legislation
05/01/18PRICE SENSITIVE
MXC MGC Derma Launches CBD Herbal Psoriasis Cream
04/01/18PRICE SENSITIVE
MXC Response to ASX query
03/01/18PRICE SENSITIVE
MXC MXC Operational Update
18/12/17PRICE SENSITIVE
MXC New Year Launch of MGC Derma CBD Psoriasis Cream Confirmed
14/12/17PRICE SENSITIVE
MXC Binding Agreement to Supply $1m CBD Extract Annually
22/11/17PRICE SENSITIVE
MXC Definitive Supply Agreement Executed with HL Pharma
20/11/17PRICE SENSITIVE
MXC First Varm Cosmo Binding Purchase Order Received
14/11/17PRICE SENSITIVE
MXC MXC Enters Multi $M Australian Pharma Market
01/11/17PRICE SENSITIVE
MXC September Quarterly Activity and Cashflow Report
01/11/17PRICE SENSITIVE
MXC First $8m Binding Cosmetics Sales Agreement Signed
30/10/17PRICE SENSITIVE
MXC $40 Million White-Label CBD Cosmetics Agreement Executed
20/10/17PRICE SENSITIVE
MXC MXC Botanic Division Operational Update
13/10/17PRICE SENSITIVE
MXC Major EU Pharma Supply Agreement Signed with Lenis
03/10/17PRICE SENSITIVE
MXC Appendix 4E and Audited 2017 Financial Report
30/08/17PRICE SENSITIVE
MXC RMIT and MGC Pharmaceuticals Sign Strategic Agreement
23/08/17PRICE SENSITIVE
MXC June Quarterly Activity and Cashflow Report
01/08/17PRICE SENSITIVE
MXC Botanical Division Update - Europe and Australia
03/07/17PRICE SENSITIVE
MXC First European Distribution Deal Signed for API Products
19/06/17PRICE SENSITIVE
MXC EU Medical Cannabis License Granted with Strategic Agreement
05/06/17PRICE SENSITIVE
MXC Trading Halt
01/06/17PRICE SENSITIVE
MXC Positive MGC Derma Clinical Test Results
22/05/17PRICE SENSITIVE
MXC CEO Appointment
10/05/17PRICE SENSITIVE
MXC Strategic Agreement Signed with RMIT
02/05/17PRICE SENSITIVE
MXC Trading Halt
01/05/17PRICE SENSITIVE
MXC New EU Sales Agreements Signed For MGC Derma
01/05/17PRICE SENSITIVE
MXC March Quarterly Activity and Cashflow Report
28/04/17PRICE SENSITIVE
MXC Successful MXC First Cannabinoid Production
10/04/17PRICE SENSITIVE
MXC European API Extraction Facility Completed
05/04/17PRICE SENSITIVE
MXC Placement of $10m Closed Significantly Oversubscribed
17/03/17PRICE SENSITIVE
MXC Trading Halt
15/03/17PRICE SENSITIVE
MXC Half Yearly Report and Accounts
28/02/17PRICE SENSITIVE
MXC Australian Legislation Changes Fast Track MXC
23/02/17PRICE SENSITIVE
MXC Cannabinoid Extraction Facility On Target Q2 Production
20/02/17PRICE SENSITIVE
MXC Medical Cannabis Clinical Study Commencing
14/02/17PRICE SENSITIVE
MXC Trading Halt
09/02/17PRICE SENSITIVE
MXC Panax Acquisition Completed
07/02/17PRICE SENSITIVE
MXC December Quarterly Activity and Cashflow Report
01/02/17PRICE SENSITIVE
MXC Commencement of Dermatological Clinical Trials
25/01/17PRICE SENSITIVE
MXC European CPNP Approval Granted for Derma Products
09/01/17PRICE SENSITIVE
MXC MXC Operations Update
22/12/16PRICE SENSITIVE
MXC New Panax Acquisition Agreement Signed, Settlement Imminent
15/12/16PRICE SENSITIVE
MXC First Major European Sales and Revenue for MGC Derma Range
02/12/16PRICE SENSITIVE
MXC Cleansing Prospectus
09/11/16PRICE SENSITIVE
MXC EU Registration Commenced for CBD Derma Product Sales
07/11/16PRICE SENSITIVE
MXC September Quarter Activity and Cashflow Report-MXC.AX
27/10/16PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Resolute Mining Ltd has told investors that a second payment has been made to the Mali government following the detention of three employees
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.